20150730-穆迪服务-Credit_Outlook_23页_2mb

Credit Outlook Summary

Core Content Overview

This document provides a detailed analysis of credit implications related to recent corporate, infrastructure, and banking developments. It highlights both credit positive and credit negative outcomes based on the financial and operational impacts of these events on the entities involved.

Main Sections and Key Information

Corporates

• Teva Pharmaceutical Industries Ltd.

  • Deal: Teva plans to acquire Allergan's generics business for $40.5 billion, with $27 billion in new debt.
  • Credit Impact: Credit negative for Teva due to increased financial leverage.
  • Allergan Impact: Credit positive for Allergan as the sale provides $36 billion in net proceeds, strengthening its balance sheet.
  • Ratings: Teva's rating downgraded to Baa1, with a review for further downgrade. Allergan's subsidiaries' ratings affirmed at Baa3 with stable outlooks.
  • Synergies: Teva expects $1.4 billion in synergies, reducing the debt/EBITDA ratio to 4.0x.
  • Copaxone: Teva's reliance on this drug will decrease, reducing its impact on profits.
  • Comparison with Mylan Deal: The Allergan deal carries a higher purchase multiple but less execution risk than the previously abandoned Mylan bid.

• Pearson's Sale of FT Group to Nikkei

  • Deal: Pearson sells FT Group for £844 million gross, providing £694 million in net proceeds.
  • Credit Impact: Credit positive for Pearson, as the proceeds will help reduce leverage and support growth in education.
  • Market Position: The sale is part of a broader strategy to reposition Pearson away from traditional journalism.
  • Ratings: Negative outlook on Pearson's Baa1 rating due to ongoing risks in its education markets and need for consistent execution.
  • Financial Metrics: Expected to maintain a Moody's-adjusted retained cash flow/net debt ratio in the high teens and an adjusted gross debt/EBITDA ratio under 3.0x.

• UK Bookmaker Ladbrokes' Merger with Gala Coral

  • Deal: Ladbrokes and Gala Coral merge, creating a new entity with a pro forma market cap of £2.3 billion.
  • Credit Impact: Credit positive due to increased scale, diversified product offering, and geographic reach.
  • Financial Impact: The merged entity will have revenues of £2.2 billion and EBITDA of £390 million.
  • Risks: Increased leverage (debt/EBITDA expected to rise to over 4x), regulatory scrutiny, and potential brand dilution.
  • Synergies: Estimated annual cost synergies of £65 million over three years.
  • Strategic Plan: Includes share issuance, dividend cuts, and investment in retail and digital divisions.

Infrastructure

• Energy Future Holdings Bankruptcy Plan

  • Deal: EFH's preferred path out of bankruptcy includes converting Oncor into a REIT, dismantling ring-fence provisions, and increasing leverage.
  • Credit Impact: Credit negative for Oncor due to the risks associated with the REIT conversion, reduced regulatory protection, and higher leverage.
  • Regulatory Concerns: PUCT may intervene to address the tax disconnect and reduce Oncor's return on equity.
  • Capital Structure: Oncor's debt/EBITDA ratio is expected to rise to over 4x.
  • Minority Investors: Borealis is a key minority investor that may help preserve ring-fence provisions.

• Korea's Nuclear Reactor Commissioning

  • Deal: KHNP and KEPCO have started commercial operations of the Shin-Wolseong 2 reactor.
  • Credit Impact: Credit positive for both companies due to increased operating cash flow and reduced reliance on LNG/oil.
  • Capacity: The reactor has 1,000 MW capacity and generates 7,900 GWh annually.
  • Funds from Operations (FFO): KHNP's FFO/debt ratio is expected to improve to 23%-28% over the next 12-18 months.
  • KEPCO's FFO: Expected to rise to 20%-23% due to lower generation costs.
  • Government Support: Demonstrates continued support for nuclear energy in Korea, setting a positive precedent for future reactor approvals.

Banks

• Argentina's Minimum Deposit Rates

  • Regulation: Central bank raised minimum deposit rates, increasing funding costs for banks.
  • Credit Impact: Credit negative due to narrowing interest margins.
  • Rate Increases: Minimum rates now up to 26.1% for deposits over ARS1 million.
  • Impact on Banks: Expected to increase annual deposit costs by ARS2 billion, raising funding costs by ~2%.
  • Other Pressures: Lending rate caps and mandatory lending requirements further reduce profitability.
  • Profitability: Despite nominal returns of 28%, real returns are near zero due to high inflation (~25%-30%).
  • Asset Holdings: Banks are increasing liquid assets like central bank bills, which yield negative real interest rates.

• Australian Major Banks' Repricing of Residential Investor Loans

  • Action: Three major Australian banks increased rates for residential investor and interest-only loans.
  • Credit Impact: Credit positive for banks as it rebalances portfolios toward safer lending.
  • Rationale: Compliance with APRA's measures to curb investment lending growth.
  • Loan-to-Value (LTV) Caps: Increased for investor loans, with ANZ and CBA at 90% and 80% respectively.
  • Interest Rates: Standard variable rates increased by 0.27%, IO and line of credit rates by 0.29%.
  • Risks: Investment and IO loans carry higher default risk and are more sensitive to interest rate changes.
  • Current Trends: Investment lending has reached record levels, contributing to house price inflation.

Summary of Key Points

• Credit Positive Events:

  • Pearson's sale of FT Group to Nikkei improves its financial position and supports strategic repositioning.
  • Korea's nuclear reactor commissioning boosts KHNP and KEPCO's operating cash flow and reduces fuel dependency.
  • UK merger of Ladbrokes and Gala Coral enhances market position and operational synergies.

• Credit Negative Events:

  • Teva's acquisition of Allergan's generics business increases financial leverage and reduces growth prospects.
  • Argentina's minimum deposit rates and lending caps narrow interest margins and reduce profitability.
  • EFH's bankruptcy plan poses risks to Oncor through REIT conversion, reduced regulatory protection, and higher leverage.

• Overall Outlook:

  • Entities involved in the credit negative events face increased financial stress and potential rating downgrades.
  • Credit positive entities are expected to benefit from improved balance sheets, strategic alignment, and operational efficiency.